SARS-CoV-2 variants reveal features critical for replication in primary human cells.
Since entering the human population, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2; the causative agent of Coronavirus Disease 2019 [COVID-19]) has spread worldwide, causing >100 million infections and >2 million deaths. While large-scale sequencing efforts have identified numero...
Guardado en:
Autores principales: | Marie O Pohl, Idoia Busnadiego, Verena Kufner, Irina Glas, Umut Karakus, Stefan Schmutz, Maryam Zaheri, Irene Abela, Alexandra Trkola, Michael Huber, Silke Stertz, Benjamin G Hale |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/942eb63eba2e43ccbc2ad9759b98db2c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2
por: Idoia Busnadiego, et al.
Publicado: (2020) -
Cathepsin W Is Required for Escape of Influenza A Virus from Late Endosomes
por: Thomas O. Edinger, et al.
Publicado: (2015) -
Application of a Biologically Contained Reporter System To Study Gain-of-Function H5N1 Influenza A Viruses with Pandemic Potential
por: Eva E. Spieler, et al.
Publicado: (2020) -
Profiling host ANP32A splicing landscapes to predict influenza A virus polymerase adaptation
por: Patricia Domingues, et al.
Publicado: (2019) -
Phosphoproteomic-based kinase profiling early in influenza virus infection identifies GRK2 as antiviral drug target
por: Emilio Yángüez, et al.
Publicado: (2018)